Successful two-day (intensive) postgraduate course on Health Technology Assessment (HTA) at Maastricht University
![HSR News-Successful two-day (intensive) postgraduate course on Health Technology Assessment (HTA) at Maastricht University](/sites/default/files/2023-03/hta_course_june_2019_4kant.png)
On 28th and 29th June 2019, 23 participants from various countries (ranging from Qatar to Mexico) successfully followed the two-day (intensive) postgraduate course on Health Technology Assessment (HTA). The faculty consisted of Professor Silvia Evers and Professor Manuela Joore of the Maastricht University.
This well evaluated in-depth course provided an overview of the theoretical and practical foundation of HTA, with a focus on trial-based economic evaluation. Major themes during this course were: Framing, Costing, Outcomes assessment and quality of life (QALY), Synthesising cost and effects, and Uncertainty and Reporting. The course was a great combination of lectures, hands-on training, and workshops, and consultations on their own research. And of course also some time for social interaction and a graduation at the end.
![HSR News-Successful two-day (intensive) postgraduate course on Health Technology Assessment (HTA) at Maastricht University 2](/sites/default/files/2023-03/hta_course_june_2019_group_pics.png)
Also read
-
Maastricht University students have won the Dutch final of the student competition Ecotrophelia, a drinking vinegar based on apple cider vinegar, fruit and herbs.
-
In the upcoming months, we’ll share tips on Instagram for our students on how to live a healthier life. Not just a random collection, but tips based on actual research happening at our faculty. The brains behind this idea are Lieve Vonken and Gido Metz, PhD candidates at CAPHRI, the Care and Public...
-
Mayke Oosterloo is a movement disorders neurologist at Maastricht UMC+ and a researcher at the MHeNs institute of Maastricht University. In the outpatient clinic and various nursing homes in Limburg, she guides and treats patients (and their loved ones) with Huntington's disease.